https://www.selleckchem.com/pr....oducts/lomeguatrib.h
Detection of kinase domain mutations is a reliable method for choosing the best treatment strategy based on patients' conditions, avoiding ineffective treatments, and running high-cost protocols in patients with acquired resistance to TKIs. Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate disease is unknown. To determine the efficacy of 5 or 10 days of remdesivir treatment compared with standard care on clinica
Like
Comment
Share
